Fundraising FoxCONFLUENCE LIFE SCIENCES, INC.
acquired by Aclaris TherapeuticsSaint Louis, US · 1 known investors
Find your way into CONFLUENCE LIFE SCIENCES, INC.
Sign up to see every warm intro you have to CONFLUENCE LIFE SCIENCES, INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CONFLUENCE LIFE SCIENCES, INC. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Technology-focused company on rational drug design for cancer and chronic inflammatory diseases (acquired by Aclaris Therapeutics in August 2017).
Founders & leadership
JB
Jennifer BohnertExecutive
WS
Walter SmithExecutive
Board
DJ
Daniel JaniakBoard director
CB
Charles BoltenBoard director
TS
Thomas SmartBoard director
KS
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 1 round · 2016
▶$4.8MraisedApr 2016 · 16 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2016 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JaniakDirector
- Jennifer BohnertExecutive Officer
- Walter SmithExecutive Officer, Director
- Joseph MonahanExecutive Officer, Director
- Charles BoltenDirector
- Thomas SmartDirector
- Kyparissia SirinakisDirector
- Offering amount
- $5.4M
- Amount sold
- $4.8M
- Minimum investment
- $1
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $289.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does CONFLUENCE LIFE SCIENCES, INC. do?
- Technology-focused company on rational drug design for cancer and chronic inflammatory diseases (acquired by Aclaris Therapeutics in August 2017).
- Who are CONFLUENCE LIFE SCIENCES, INC.'s investors?
- CONFLUENCE LIFE SCIENCES, INC.'s investors include Epidarex Capital.
- How much funding has CONFLUENCE LIFE SCIENCES, INC. raised?
- CONFLUENCE LIFE SCIENCES, INC. has disclosed $4.8M raised across 1 round.
- Who acquired CONFLUENCE LIFE SCIENCES, INC.?
- CONFLUENCE LIFE SCIENCES, INC. was acquired by Aclaris Therapeutics.
- Where is CONFLUENCE LIFE SCIENCES, INC. headquartered?
- CONFLUENCE LIFE SCIENCES, INC. is headquartered in Saint Louis, US.